Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACA, acknowledge, ADF, admit, allegedly, amid, amidst, AoD, articulated, ASR, bargaining, belief, big, Boston, breakdown, bulk, bulleted, caregiver, Carlo, chaired, charitable, charity, citizen, climate, Colleen, concession, conjunction, constitutionality, Council, creative, culture, curriculum, deadline, dental, depressed, depth, dignity, disability, dissemination, diversified, donated, elevated, embrace, energy, equitable, ESG, ethnicity, explanatory, explore, exploring, faithfully, feedback, fostering, foundational, Franklin, freestanding, fueling, gender, gift, Globe, hold, hone, hybrid, hygiene, IBH, ID, Inflexxion, inspiring, intensify, invoice, issuable, leave, length, LifeBOAT, listening, live, lived, living, matched, matching, mentorship, merchandise, misidentification, Monte, Neuroscience, operationalized, optimize, overestimated, parental, pendency, perspective, philanthropy, Pierce, Poison, pool, processor, proud, Provisional, push, race, real, recycling, refreshing, refund, regular, reissuance, rejection, resource, richer, risky, row, saleable, salesforce, SAMHSA, SASB, Shire, skill, snapshot, speculative, spiked, stakeholder, stewardship, strive, summer, Summit, surge, survey, surveying, Takeda, tender, tendered, theory, tied, Top, traceable, Tupper, turnover, unanimously, uncompromising, underestimated, unissued, unlawful, unprecedented, unprocessed, unseen, unwavering, vaccinated, vision, waste, water, week, weekly, window, withheld, workforce, workplace, workweek, wrongdoing
Removed:
accumulation, aimed, Alison, Amherst, answered, authored, avoid, bearing, Biomolecular, Brannelly, broader, cancer, classification, clinician, collectability, collectible, CombinatoRx, concentrated, conditionally, Cornell, coupled, curtail, disproportionate, dispute, Dyax, emphasize, Engineering, enjoined, eventually, evident, Fleming, GlaxoSmithKline, graduated, identifiable, identifying, influenced, internationally, invalidity, inventor, Karyopharm, LA, leader, led, legacy, litigated, Longwood, mandating, maximum, moved, operational, opportunity, OvaScience, owed, Paul, penalty, permanent, poster, prorated, realizability, recruiting, reflecting, relate, remeasured, restricting, reversed, Schroeder, Secretary, short, standby, startup, Steering, surrendered, Theodore, threat, timeline, Treasurer, true, unrelated, venture, Verastem
Filing tables
Filing exhibits
Associated COLL transcripts
COLL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-234329 and 333-237200 on Form S-3 and Registration Statement Nos. 333-207744, 333-218767, 333-225498, 333-233092, 333-245649, and 333-258752 on Form S-8 of our reports dated February 24, 2022, relating to the consolidated financial statements of Collegium Pharmaceutical, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of Collegium Pharmaceutical, Inc. for the year ended December 31, 2021.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
February 24, 2022